Thyrocare

Last updated

Thyrocare Technologies Ltd.
Company type Public company
IndustryHealthcare
Founded1996;28 years ago (1996)
Founder
Headquarters
Navi Mumbai, Maharashtra
,
India
Number of locations
1,122 outlets [1]  (2021)
Area served
 India
Nepal
Bangladesh
Middle East
Key people
Rahul Guha (Chairman, CEO and MD) [2]
RevenueIncrease2.svg₹618 crore (US$77 million) (FY22) [3]
Increase2.svg₹228 crore (US$29 million) (FY22) [3]
Increase2.svg₹176 crore (US$22 million) (FY22) [3]
Owner API Holdings (66.1%)
Number of employees
2,000+ [4]  (2021)
Parent API Holdings
Website www.thyrocare.com

Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. [1] As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East. [1] [5]

Contents

On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, [6] making Thyrocare the first Indian listed company to be acquired by a startup. [7] [8] [9]

History

Old logo of Thyrocare Thyrocare Logo.png
Old logo of Thyrocare

Thyrocare was started in 1996, by A. Velumani, a former scientist at Bhabha Atomic Research Centre (BARC) in Mumbai. The first laboratory was set up in Byculla, Mumbai, with an initial focus on thyroid testing. [5] [10] The laboratory was later shifted to a larger set-up, its main headquarters and central processing laboratory at Navi Mumbai. The company introduced a franchisee model for procuring samples to be sent for testing at their central laboratory in Mumbai. [10]

In 2010, Thyrocare raised its first private equity funding of ₹188 crore from New Delhi-based CX Partners in exchange for a 30% stake. [11] It set up a subsidiary, Nuclear Healthcare Limited, which uses PET-CT to detect and locate cancerous cells. [12] [13] [14]

In 2014, Siemens Healthcare's diagnostic division installed its world's largest laboratory automation track – Aptio Automation – at its laboratory in Mumbai. [15]

In April 2016, Thyrocare made its initial public offering (IPO), [16] and became the second diagnostic firm in India to be listed on BSE and NSE. [13]

In 2021, PharmEasy parent API Holdings acquired a 66.1% stake in Thyrocare. [17]

In 2023, Thyrocare integrated AI-based devices to automate manual microscopy across its network with SigTuple's AI100. [18]

Services

Thyrocare initially started with thyroid testing but now has more than 350 tests and packages, along with 83 odd profiles comprising different tests for preventive care and wellness under its brand Aarogyam. [12] During the peak of COVID-19 pandemic, Thyrocare carried out more than 8 lakh tests per month.[ citation needed ] Thyrocare's 68% of business comes from the DSA model to promote its services.[ citation needed ]

Controversies

In April 2020, Brihanmumbai Municipal Corporation issued a show cause notice to Thyrocare over lapses in its testing of Covid-19 samples and ordered the company to stop testing as "incomplete or wrong information about patients were found in the reports". [19] In May 2020, Panvel Municipal Corporation ordered Thyrocare to stop testing samples in Panvel city limits as the lab was producing false positive reports. [20] In June 2020, the Navi Mumbai Municipal Corporation demanded cancellation of Thyrocare's registration after discrepancies in the lab's report led to a patient's death, [21] while Thane Municipal Corporation banned Thyrocare in the city for producing false positive reports. [22] In July 2020, a Thyrocare lab in Pune was banned from conducting Covid-19 tests after producing false positive reports. [23]

Related Research Articles

<span class="mw-page-title-main">Agilent Technologies</span> American technology company

Agilent Technologies, Inc. is a global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.

<span class="mw-page-title-main">Navi Mumbai</span> Planned city in Maharashtra, India

Navi Mumbai is a planned city next to Mumbai (Bombay), located in the Konkan division of the western Indian state of Maharashtra, on the mainland of India. Navi Mumbai is situated across two districts, Thane (Taana) & Raigad. It is a part of the Mumbai Metropolitan Area.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

<span class="mw-page-title-main">Apollo Hospitals</span> Indian hospital chain

Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the largest for-profit private hospital network in India, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries.

Siemens Healthineers is a German company which provides healthcare services. It was spun off from its parent company Siemens in 2017, which retains a 75% stake. Siemens Healthineers is the parent company for several medical technology companies and is headquartered in Erlangen, Germany.

Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.

<span class="mw-page-title-main">Max Healthcare</span> Indian multi-specialty hospital chain

Max Healthcare Institute Limited is an Indian for-profit private hospital chain headquartered in Delhi. Max Healthcare owns and operates 17 hospitals with 3500+ beds and 4800+ clinicians across the Delhi National Capital Region, Mohali, Bathinda, Dehradun and Mumbai. It also operates Patient Assistance Centers in Nairobi, Lagos and Dubai.

<span class="mw-page-title-main">Panvel railway station</span> Railway station in Mumbai, India

Panvel railway station, station code is: PL(suburban)/PNVL(mainline)) is a railway station on the Harbour Line and Central line of the Mumbai Suburban Railway network.

<span class="mw-page-title-main">Adani Enterprises</span> Indian multinational holding company

Adani Enterprises Limited (AEL) is an Indian multinational publicly-listed holding company and a part of Adani Group. It is headquartered in Ahmedabad and primarily involved in mining and trading of coal and iron ore. Through its various subsidiaries, it also has business interests in airport operations, edible oils, road, rail and water infrastructure, data centers, and solar manufacturing, among others.

<span class="mw-page-title-main">Mankind Pharma</span> Indian pharmaceutical and healthcare products company

Mankind Pharma is an Indian pharmaceutical and healthcare products company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.

<span class="mw-page-title-main">Piramal Group</span> Indian conglomerate

The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.

<span class="mw-page-title-main">Aster DM Healthcare</span> Healthcare company in Gulf countries and India

Aster DM Healthcare Limited is a multinational for-profit private hospital network founded by Azad Moopen in 1987. The company has its corporate headquarters in Dubai, UAE, and is registered in Bangalore, India. Aster DM Healthcare currently operates hospitals, medical centres, diagnostic centres, laboratories and pharmacies in six GCC countries and India. The corporation works in a variety of economic sectors through its brands Aster, Medcare, and Access.

<span class="mw-page-title-main">MedPlus</span> Indian pharmaceutical retailer

MedPlus Health Services is an Indian pharmacy retail chain, headquartered in Hyderabad. MedPlus is the second largest pharmacy chain in India, operating over 4,230+ pharmacy stores across 600 cities, as of 2024.

Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera.

<span class="mw-page-title-main">Arvind Lal</span>

Arvind Lal is an Indian billionaire, pathologist, medical administrator and the chairman and managing director of Dr Lal PathLabs, a medical diagnostic centre in Delhi. A medical graduate and a medical academic, he is reported to have modernized Indian medical diagnostics and initiated the first Public Private Partnership (PPP) in the field of laboratory testing in India. He holds the rank of a Brigadier in the Indian Armed Forces, an honorary rank conferred by the Army. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2009, for his contributions to Medicine.

Arokiaswamy Velumani is an Indian entrepreneur. He is the founder of Thyrocare Technologies Ltd. a chain of diagnostic and preventive care laboratories headquartered in Navi Mumbai. He is the founder of Nueclear Healthcare Limited, a radiology diagnostics company affiliated to Thyrocare.

<span class="mw-page-title-main">Metropolis Healthcare</span> Indian multinational diagnostic lab company

Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019.

Agilus Diagnostics Limited is an Indian multinational diagnostics company providing diagnostic services in pathology and radiology. Agilus Diagnostics has its headquarters and corporate office in Gurgaon.

PharmEasy is an Indian e-pharmacy company that sells medicines, diagnostics and telehealth online.

Tata 1mg, previously 1mg, is a healthcare platform based in Gurugram, India. It provides services, including e-pharmacy, diagnostics, e-consultation, and health content. It was founded in April 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan.

References

  1. 1 2 3 "Thyrocare Technologies IPO today: 10 things to know before investing". The Financial Express. 27 April 2016. Retrieved 15 September 2016.
  2. ↑ "Thyrocare Technologies Ltd". Reuters. Retrieved 7 May 2024.
  3. 1 2 3 "Annual Report 2021-22" (PDF). Thyrocare. Retrieved 11 February 2023.
  4. ↑ "Owler Profile: Thyrocare". Owler. 30 June 2021. Retrieved 30 June 2021.
  5. 1 2 "Thyrocare Technologies profit, revenue, etc!". economictimes.indiatimes.com. The economic times India. 30 June 2021. Retrieved 30 June 2021.
  6. ↑ Dhanjal, Swaraj Singh (25 June 2021). "PharmEasy to acquire 66% stake in diagnostic chain Thyrocare for ₹4,500 cr". mint. Retrieved 1 September 2021.
  7. ↑ "PharmEasy opens up quicker public listing options with its acquisition of Thyrocare". Business Insider. Retrieved 3 July 2021.
  8. ↑ "PharmEasy To Acquire 66.1% Stake In Thyrocare For Rs 4,546 Crore". Moneycontrol. 25 June 2021. Retrieved 3 July 2021.
  9. ↑ Datta, PT Jyothi (25 June 2021). "PharmEasy buys out Thyrocare for ₹4,546 cr". @businessline. Retrieved 3 July 2021.
  10. 1 2 "Thyrocare Technologies: Testing new waters in medical diagnostics, Hidden Gems". forbesindia.com. 10 September 2015. Retrieved 24 September 2016.
  11. ↑ "A panacea for the masses". thesmartceo.in. The Smart CEO. 1 December 2012. Retrieved 15 September 2016.
  12. 1 2 "Thyrocare: Strong base, multiple new triggers". Business Standard. 25 April 2016. Retrieved 15 September 2016.
  13. 1 2 "Thyrocare: Strong base, multiple new triggers". SmartInvestor.in. SmartInvestor. 26 April 2016. Retrieved 16 September 2016.
  14. ↑ "Nueclear Healthcare Limited Secures INR 22 Crores From Norwest Venture Partners (NVP)". marketwired. 18 January 2013. Retrieved 16 September 2016.
  15. ↑ "Siemens installs 'Aptio automation solution' lab at Thyrocare, Diagnostics". Pharmabiz.com. 22 July 2014. Retrieved 16 September 2016.
  16. ↑ "Thyrocare Technologies IPO draws huge response, subscribed 73.24x". ET Markets. 30 April 2016. Retrieved 16 September 2016.
  17. ↑ "EXCLUSIVE | API Holdings' Acquisition Of Thyrocare Will Create One-stop Shop For Healthcare Solutions, Says PharmEasy's Siddharth Shah". Moneycontrol. 25 June 2021. Retrieved 9 December 2021.
  18. ↑ https://health.economictimes.indiatimes.com/news/diagnostics/thyrocare-to-automate-manual-microscopy-across-its-network-with-sigtuples-ai100/98170440
  19. ↑ "BMC Asks Thyrocare to Stop Testing for Coronavirus Over 'Serious' Lapses in Patients' Reports". News18. 28 April 2020. Retrieved 10 February 2023.
  20. ↑ Assainar, Raina (12 May 2020). "PMC orders Thyrocare not to test swab samples". The Hindu. Retrieved 10 February 2023.
  21. ↑ "NMMC: Scrap registration of lab for fiasco". The Times of India. 8 June 2020. Retrieved 10 February 2023.
  22. ↑ Pathak, Kalpana; Leo, Leroy (12 June 2020). "Mumbai's ban on two labs to hit covid-19 testing in the city". mint. Retrieved 10 February 2023.
  23. ↑ "Pvt lab botches result, banned from nCoV tests". The Times of India. 13 July 2020. Retrieved 10 February 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.